Precigen (PGEN) News Today $0.82 -0.06 (-6.82%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Precigen’s Promising Developments and Strategic Focus Drive Buy RatingNovember 15 at 4:42 PM | markets.businessinsider.comStifel Nicolaus Keeps Their Buy Rating on Precigen (PGEN)November 15 at 4:42 PM | markets.businessinsider.comHC Wainwright Reiterates Buy Rating for Precigen (NASDAQ:PGEN)HC Wainwright restated a "buy" rating and issued a $4.00 price objective on shares of Precigen in a report on Friday.November 15 at 8:06 AM | marketbeat.comPrecigen, Inc.: Precigen Reports Third Quarter 2024 Financial Results and Business UpdatesNovember 15 at 6:20 AM | finanznachrichten.dePrecigen’s Strategic Advancements and FDA Alignment Bolster Buy RatingNovember 15 at 3:41 AM | markets.businessinsider.comPrecigen Reports Third Quarter 2024 Financial Results and Business UpdatesNovember 14 at 4:30 PM | prnewswire.comPrecigen (NASDAQ:PGEN) Shares Cross Below 200 Day Moving Average - Here's WhyPrecigen (NASDAQ:PGEN) Share Price Crosses Below Two Hundred Day Moving Average - Here's WhyNovember 14 at 3:53 AM | marketbeat.comAnalysts Set Precigen, Inc. (NASDAQ:PGEN) Target Price at $7.00November 13, 2024 | americanbankingnews.comPrecigen to Participate in the Stifel 2024 Healthcare ConferenceNovember 12, 2024 | finance.yahoo.comPrecigen to Participate in the Stifel 2024 Healthcare ConferenceNovember 12, 2024 | prnewswire.comPrecigen, Inc. (NASDAQ:PGEN) Given Average Rating of "Moderate Buy" by BrokeragesPrecigen, Inc. (NASDAQ:PGEN - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the five research firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating and four have issued a buy raNovember 6, 2024 | marketbeat.comIridian Asset Management LLC CT Has $3.58 Million Stock Position in Precigen, Inc. (NASDAQ:PGEN)Iridian Asset Management LLC CT raised its stake in Precigen, Inc. (NASDAQ:PGEN - Free Report) by 82.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,775,960 shares of the biotechnology cOctober 31, 2024 | marketbeat.comShould you Hold Precigen (PGEN)?October 18, 2024 | msn.comPrecigen, Inc. (NASDAQ:PGEN) Given Consensus Rating of "Moderate Buy" by BrokeragesPrecigen, Inc. (NASDAQ:PGEN - Get Free Report) has been given an average recommendation of "Moderate Buy" by the five brokerages that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating and four have assigned a buy rating to the comOctober 12, 2024 | marketbeat.comPrecigen (NASDAQ:PGEN) Shares Cross Below 200 Day Moving Average of $1.36Precigen (NASDAQ:PGEN) Stock Crosses Below Two Hundred Day Moving Average of $1.36October 3, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Inspire Medical Systems (INSP) and Precigen (PGEN)October 1, 2024 | markets.businessinsider.comPrecigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have been given an average rating of "Moderate Buy" by the five brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and four have assigned a buySeptember 17, 2024 | marketbeat.comPrecigen to Participate in the 2024 Cantor Global Healthcare ConferenceSeptember 16, 2024 | prnewswire.com3 Penny Stocks To Buy With Just $50September 15, 2024 | 247wallst.comWhile institutions own 26% of Precigen, Inc. (NASDAQ:PGEN), private equity firms are its largest shareholders with 43% ownershipSeptember 12, 2024 | finance.yahoo.com3 Penny Stocks to Buy With $500August 30, 2024 | 247wallst.comPrecigen, Inc. (NASDAQ:PGEN) Given Average Recommendation of "Moderate Buy" by BrokeragesPrecigen, Inc. (NASDAQ:PGEN - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the five analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and four have issued a buy rating on the coAugust 23, 2024 | marketbeat.comQ3 2024 EPS Estimates for Precigen, Inc. (NASDAQ:PGEN) Raised by HC WainwrightPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Investment analysts at HC Wainwright boosted their Q3 2024 EPS estimates for shares of Precigen in a research note issued on Thursday, August 15th. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will earn ($0.07) per sharAugust 19, 2024 | marketbeat.comPrecigen Second Quarter 2024 Earnings: Misses ExpectationsAugust 17, 2024 | finance.yahoo.comPrecigen, Inc. (NASDAQ:PGEN) to Post FY2026 Earnings of $0.02 Per Share, HC Wainwright ForecastsPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Analysts at HC Wainwright dropped their FY2026 EPS estimates for shares of Precigen in a report released on Thursday, August 15th. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will post earnings per share of $0.02 for tAugust 16, 2024 | marketbeat.comBuy Rating Affirmed for Precigen Amid Promising PRGN-2012 Clinical Data and Strategic FocusAugust 15, 2024 | markets.businessinsider.comPrecigen (NASDAQ:PGEN) Given New $7.00 Price Target at JMP SecuritiesJMP Securities decreased their price target on Precigen from $14.00 to $7.00 and set a "market outperform" rating on the stock in a research note on Thursday.August 15, 2024 | marketbeat.comPrecigen, Inc. (NASDAQ:PGEN) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | msn.comPrecigen, Inc.: Precigen Reports Second Quarter and First Half 2024 Financial Results and Business UpdatesAugust 15, 2024 | finanznachrichten.deWhy Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving PremarketAugust 15, 2024 | msn.comPGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q2 2024August 15, 2024 | markets.businessinsider.comPrecigen Reports Second Quarter and First Half 2024 Financial Results and Business UpdatesAugust 14, 2024 | prnewswire.comPrecigen, Inc. (NASDAQ:PGEN) SVP Acquires $49,999.55 in StockAugust 14, 2024 | insidertrades.comPrecigen earnings: here's what Wall Street expectsAugust 14, 2024 | markets.businessinsider.comWeekly Review: ANTX Downsizes, ALDX Aces Dry Eye Disease Trial, FDA Oks 1st Epinephrine Nasal SprayAugust 11, 2024 | nasdaq.comPrecigen (PGEN) Scheduled to Post Quarterly Earnings on WednesdayPrecigen (NASDAQ:PGEN) will be releasing earnings after the market closes on Wednesday, August 14, Zacks reports.August 10, 2024 | marketbeat.comPrecigen to Announce Second Quarter and First Half 2024 Financial Results on August 14thAugust 9, 2024 | prnewswire.comPrecigen (NASDAQ:PGEN) Shares Pass Below 200-Day Moving Average of $1.47Precigen (NASDAQ:PGEN) Stock Crosses Below Two Hundred Day Moving Average of $1.47August 9, 2024 | marketbeat.comPrecigen Announces Pricing of $30.0 Million Public Offering of Common StockAugust 7, 2024 | prnewswire.comBuy Rating Backed by Strategic Focus and Solid Clinical Pipeline at PrecigenAugust 7, 2024 | markets.businessinsider.comPrecigen to shed 20% of workforce, focus on PRGN-2012 gene therapyAugust 6, 2024 | seekingalpha.comPrecigen Announces Proposed $30 Million Public Offering of Common StockAugust 6, 2024 | prnewswire.comPrecigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy LaunchAugust 6, 2024 | prnewswire.comPrecigen (NASDAQ:PGEN) Upgraded at StockNews.comStockNews.com raised shares of Precigen to a "sell" rating in a research note on Thursday.August 1, 2024 | marketbeat.comPrecigen, Inc.'s (NASDAQ:PGEN) Shift From Loss To ProfitJuly 31, 2024 | finance.yahoo.comPrecigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five analysts that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation and four have given a buy recommendation toJuly 29, 2024 | marketbeat.comPrecigen, Inc.: Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy LaunchJuly 23, 2024 | finanznachrichten.dePrecigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy LaunchJuly 23, 2024 | prnewswire.comPGEN Aug 2024 2.500 put (PGEN240816P00002500)July 21, 2024 | finance.yahoo.comSanders Morris Harris LLC Invests $1.02 Million in Precigen, Inc. (NASDAQ:PGEN)Sanders Morris Harris LLC acquired a new position in Precigen, Inc. (NASDAQ:PGEN - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 705,000 shares of the biotechnology company's stock, valued atJune 22, 2024 | marketbeat.com Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address The Tesla Trade Is Back In Business (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla. Discover how to trade Tesla, simply follow this link here. PGEN Media Mentions By Week PGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PGEN News Sentiment▼0.260.56▲Average Medical News Sentiment PGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PGEN Articles This Week▼122▲PGEN Articles Average Week Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CLLS News Today LUNA News Today PIRS News Today ERAS News Today ABCL News Today LQDA News Today PCRX News Today IMNM News Today ANNX News Today ABUS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PGEN) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precigen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
